Abstract
AIM: To explore how often a diagnosis of gastric neoplasia is made on routine, non-targeted biopsies taken for determination of Helicobacter pylori status, compared with directed biopsies from endoscopically abnormal mucosa. METHODS: Records of all patients with a biopsy diagnosis of gastric cancer or dysplasia during a two year period were reviewed to determine whether the biopsy had been targeted at an area of mucosal abnormality, and whether there was any evidence of dysplasia or malignancy before endoscopy. RESULTS: Of the 8907 endoscopic examinations that included biopsy, histology showed malignancy in 115 cases and dysplasia in 20. Of these, in 128 cases the biopsies were targeted from focal abnormal areas of mucosa, and six were from areas of diffuse mucosal thickening. In one case, adenocarcinoma was diagnosed in a patient with a "normal" endoscopic appearance; this patient was undergoing repeat endoscopy for previous dysplasia. CONCLUSIONS: Gastric malignancy or dysplasia was detected histologically in 1.5% of endoscopies that included biopsy. The performance of routine biopsies not targeted at a visible lesion from patients without previous diagnosis of neoplasia did not increase the detection of gastric malignancy. Such biopsies are indicated, however, if histological aspects of a patient's gastritis (such as atrophy or intestinal metaplasia) influence the clinical management, as in the treatment of helicobacter gastritis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barthel J. S., Everett E. D. Diagnosis of Campylobacter pylori infections: the "gold standard" and the alternatives. Rev Infect Dis. 1990 Jan-Feb;12 (Suppl 1):S107–S114. doi: 10.1093/clinids/12.supplement_1.s107. [DOI] [PubMed] [Google Scholar]
- Christensen A. H., Gjørup T., Hilden J., Fenger C., Henriksen B., Vyberg M., Ostergaard K., Hansen B. F. Observer homogeneity in the histologic diagnosis of Helicobacter pylori. Latent class analysis, kappa coefficient, and repeat frequency. Scand J Gastroenterol. 1992 Nov;27(11):933–939. doi: 10.3109/00365529209000166. [DOI] [PubMed] [Google Scholar]
- Cutler A. F., Havstad S., Ma C. K., Blaser M. J., Perez-Perez G. I., Schubert T. T. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 1995 Jul;109(1):136–141. doi: 10.1016/0016-5085(95)90278-3. [DOI] [PubMed] [Google Scholar]
- Dixon M. F., Genta R. M., Yardley J. H., Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996 Oct;20(10):1161–1181. doi: 10.1097/00000478-199610000-00001. [DOI] [PubMed] [Google Scholar]
- Kolts B. E., Joseph B., Achem S. R., Bianchi T., Monteiro C. Helicobacter pylori detection: a quality and cost analysis. Am J Gastroenterol. 1993 May;88(5):650–655. [PubMed] [Google Scholar]
- Malfertheiner P., Mégraud F., O'Morain C., Bell D., Bianchi Porro G., Deltenre M., Forman D., Gasbarrini G., Jaup B., Misiewicz J. J. Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol. 1997 Jan;9(1):1–2. doi: 10.1097/00042737-199701000-00002. [DOI] [PubMed] [Google Scholar]
- Price A. B. The Sydney System: histological division. J Gastroenterol Hepatol. 1991 May-Jun;6(3):209–222. doi: 10.1111/j.1440-1746.1991.tb01468.x. [DOI] [PubMed] [Google Scholar]
- Sue-Ling H. M., Johnston D., Martin I. G., Dixon M. F., Lansdown M. R., McMahon M. J., Axon A. T. Gastric cancer: a curable disease in Britain. BMJ. 1993 Sep 4;307(6904):591–596. doi: 10.1136/bmj.307.6904.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wyatt J. I. Histopathology of gastroduodenal inflammation: the impact of Helicobacter pylori. Histopathology. 1995 Jan;26(1):1–15. doi: 10.1111/j.1365-2559.1995.tb00614.x. [DOI] [PubMed] [Google Scholar]